Covid Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Indeed beyond the wire. the cabinet will meet virtually this afternoon, a press conference the prime minister planned to have will still go ahead and he will make a statement to parliament this afternoon. what has proved very popular with his backbenchers is the decision to remove all of the existing restrictions, including the need to self—isolate. far more controversial, notjust with the opposition but inside government itself, is the idea of phasing out the access to free covid tests. maw; the access to free covid tests. many thanks, iain — the access to free covid tests. many thanks, i...

Will see if it pays off for glenn youngkin. >> martha: juan, obviously education has more typically been a democrat issue. we know that as katie just said, randi weingarten was brought out on stage last night. she is obviously head of one of the biggest teachers unions in the country. >> we have controversial figure in the covid phase in education. so, you know, what do you think about how he has tried to close this and bringing all of the big names to virginia as this thing got tighter and tighter? >> juan: well, it's all about turnout, martha. you know, and for the democrats, you have to kee...

Third dose. jim? >> dr. fauci also saying he believes three doses will become the norm for vaccination. brynn gingras, thanks so much. so what is on president biden's agenda for this fall? let's bring in cnn political analyst natasha alford. president biden wants to make a speech on the covid phase. that is an enormous focus of this administration. they know the president's approval rating is riding a lot on how well they handle the pandemic going forward. what else is on the agenda in the coming weeks? >> yes. well, jim, covid-19 has to be a priority. you know, so many of president biden's ...

Bharat Biotech's Covaxin shows 77.8% efficacy in Phase 3 trial Bharat Biotech on Saturday announced the efficacy analysis data from Phase 3 clinical trials of its Covid vaccine Covaxin. The vaccine has been found to be 77.8 per cent effective. advertisement UPDATED: July 3, 2021 08:49 IST Bharat Biotech on Saturday announced that Covaxin has been found to be 77.8 per cent effective against symptomatic Covid-19. (Photo: File) Bharat Biotech concluded the final analysis of its Covid-19 vaccine Covaxin and announced the safety and efficacy analysis data from Phase 3 clinical trials on Saturday. ...

3128 Hyderabad, July 3 Bharat Biotech’s Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic Covid and 65.2 per cent protection against the new Delta variant. The company on Saturday said it concluded the final analysis of Covaxin efficacy from Phase 3 trials. The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic Covid cases while safety analysis shows adverse events reported were similar to placebo, with 12 per cent of subjects experiencing commonly known side-effects and less than 0.5 per cent feeling serious adverse events...